A randomized, double-blind, placebo-controlled phase III study of cisplatin plus a fluoropyrimidine with or without ramucirumab as first-line therapy in patients with metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma (RAINFALL, NCT02314117) Meeting Abstract
| Authors: | Fuchs, C. S.; Tabernero, J.; Al-Batran, S. E.; Chau, I.; Ilson, D. H.; Van Cutsem, E.; Shitara, K.; Ferry, D.; Emig, M.; Vanvoorden, V.; Hsu, Y. Z.; Xu, Y. H.; Sashegyi, A.; Das, M.; Shah, M. A. |
| Abstract Title: | A randomized, double-blind, placebo-controlled phase III study of cisplatin plus a fluoropyrimidine with or without ramucirumab as first-line therapy in patients with metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma (RAINFALL, NCT02314117) |
| Meeting Title: | 2016 Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2016 Jan 21-23 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-02-01 |
| Language: | English |
| ACCESSION: | WOS:000378109600173 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2016.34.4_suppl.tps178 |
| Notes: | Meeting Abstract: TPS178 -- Gastrointestinal Cancers Symposium -- JAN 21-23, 2016 -- San Francisco, CA -- S -- Source: Wos |
